- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Apnea, Obstructive in South Africa
Total 896 results
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPDUnited States, France, Poland, South Africa, Canada, Germany
-
GlaxoSmithKlineCompletedAsthmaGermany, South Africa, Bulgaria
-
SunovionCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Boston Scientific CorporationCompletedAsthmaSpain, Italy, Germany, Netherlands, Australia, Czechia, South Africa, United Kingdom
-
Elpen Pharmaceutical Co. Inc.RecruitingCopd | COPD ExacerbationGreece
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Respicardia, Inc.Recruiting
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Russian Federation, Estonia, Netherlands, South Africa, Korea, Republic of, Slovenia, New Zealand, Finland, Latvia, Lithuania, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Romania, Ukraine, Estonia, Russian Federation, South Africa, Sweden, Netherlands, Slovakia
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldRecruitingIleus | Small Bowel Obstruction | Intestinal FailureUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia
-
US Department of Veterans AffairsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveSouth Africa, United States, Canada, Ukraine, United Kingdom, Denmark, Czechia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Chile, South Africa, Romania, Slovakia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Novartis PharmaceuticalsCompletedCOPDSpain, Germany, Belgium, Poland, South Africa, Australia, Greece, Israel, Sweden, Hong Kong, Thailand, Bulgaria, Singapore, Denmark, Finland, Hungary, Romania, Malaysia
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, United Kingdom
-
Flinders UniversityCompletedChronic Obstructive Pulmonary Disease | DyspneaAustralia, New Zealand
-
AstraZenecaQuintiles, Inc.Completed
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Austria, Canada, Germany, Greece, New Zealand, Norway, Slovakia, South Africa, Sweden
-
Boehringer IngelheimCompleted12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPDPulmonary Disease, Chronic ObstructiveGermany, Italy, Switzerland, South Africa
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseRomania, Lithuania, Canada, France, Hungary, India, South Africa, Korea, Republic of, Latvia, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveTaiwan, Korea, Republic of, China, Australia
-
SunovionCompleted
-
University of WashingtonNational Institute of Nursing Research (NINR)CompletedEnd Stage Liver Disease | Chronic Obstructive Pulmonary Disease (COPD) | Advanced Cancer | Congestive Heart Failure | Restrictive Lung DiseaseUnited States
-
Medical University of South CarolinaCompletedPulmonary Disease, Chronic Obstructive | Telemedicine | Cigarette SmokingUnited States
-
Soroka University Medical CenterRecruitingLung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive | Asthma | COPDIsrael
-
GlaxoSmithKlineCompletedAsthmaUnited States, South Africa
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)CompletedLung Diseases, Obstructive | Pulmonary Disease, Chronic ObstructiveCosta Rica
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Ukraine, United States, Estonia, South Africa, Sweden, Norway, Russian Federation, Korea, Republic of
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany, Netherlands, Denmark, France, South Africa, Austria, Belgium, Sweden
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, United Kingdom, Italy, United States, Romania
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
PfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Sweden, Australia, Hungary, Bulgaria, South Africa, Poland, Slovakia, India, Canada, Argentina, Czech Republic, Chile, New Zealand, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
MedImmune LLCCompletedApnea | Pneumonia | Bronchiolitis | Respiratory InfectionsUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Aeris TherapeuticsCompletedChronic Obstructive Pulmonary Disease | Pulmonary EmphysemaUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Ukraine, Spain, South Africa, Italy
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseSpain, United States, Belgium
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States